# Robert Knight

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-knight/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,003 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 58 |
| i10-index | 141 |
| Last Known Institution | King's College London |
| OpenAlex ID | https://openalex.org/A5050333678 |
| ORCID iD | https://orcid.org/0000-0001-9920-836X |
| Works | 265 |

## Researcher papers

- [Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma](https://scholariq.org/papers/lenalidomide-bortezomib-and-dexamethasone-combination-therapy-in-patients-with/)
- [Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma](https://scholariq.org/papers/lenalidomide-and-dexamethasone-in-transplant-ineligible-patients-with-myeloma/)
- [A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma](https://scholariq.org/papers/a-randomized-phase-2-study-of-lenalidomide-therapy-for-patients-with-relapsed-or/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [King's College London](https://scholariq.org/institutions/king-s-college-london/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.